 BRIDGEWATER, N.J., Oct. 28, 2020 PRNewswire Insmed Incorporated Nasdaq:INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the European Commission EC has granted marketing authorization for... 